Diclofenac-beta-cyclodextrin binary systems: physicochemical characterization and in vitro dissolution and diffusion studies
- PMID: 16354006
- PMCID: PMC2750392
- DOI: 10.1208/pt060358
Diclofenac-beta-cyclodextrin binary systems: physicochemical characterization and in vitro dissolution and diffusion studies
Abstract
The aim of this work was to study the influence of beta-cyclodextrin (beta-CD) on the biopharmaceutic properties of diclofenac (DCF). To this purpose the physicochemical characterization of diclofenac-beta-cyclodextrin binary systems was performed both in solution and solid state. Solid phase characterization was performed using differential scanning calorimetry (DSC), powder x-ray diffractometry (XRD), and Fourier transform infrared spectroscopy (FTIR). Phase solubility analyses, and in vitro permeation experiments through a synthetic membrane were performed in solution. Moreover, DCF/beta-CD interactions were studied in DMSO by 1H nuclear magnetic resonance (NMR) spectroscopy. The effects of different preparation methods and drug-to-beta-CD molar ratios were also evaluated. Phase solubility studies revealed 1:1 M complexation of DCF when the freeze-drying method was used for the preparation of the binary system. The true inclusion for the freeze-dried binary system was confirmed by 1H NMR spectroscopy, DSC, powder XRD, and IR studies. The dissolution study revealed that the drug dissolution rate was improved by the presence of CDs and the highest and promptest release was obtained with the freeze-dried binary system. Diffusion experiments through a silicone membrane showed that DCF diffusion was higher from the saturated drug solution (control) than the freeze-dried inclusion complexes, prepared using different DCF-beta-CD molar ratios. However, the presence of the inclusion complex was able to stabilize the system giving rise to a more regular diffusion profile.
Similar articles
-
Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.Eur J Pharm Biopharm. 2008 Nov;70(3):819-27. doi: 10.1016/j.ejpb.2008.06.024. Epub 2008 Jul 4. Eur J Pharm Biopharm. 2008. PMID: 18655829
-
Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.Eur J Pharm Biopharm. 2007 Sep;67(2):531-9. doi: 10.1016/j.ejpb.2007.03.005. Epub 2007 Mar 13. Eur J Pharm Biopharm. 2007. PMID: 17451924
-
Synthesis and characterization of binary and ternary complexes of diclofenac with a methyl-beta-CD and monoethanolamine and in vitro transdermal evaluation.Eur J Med Chem. 2010 Sep;45(9):4079-88. doi: 10.1016/j.ejmech.2010.05.068. Epub 2010 Jun 8. Eur J Med Chem. 2010. PMID: 20566230
-
Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.J Pharm Biomed Anal. 2008 Jul 15;47(3):535-40. doi: 10.1016/j.jpba.2008.02.006. Epub 2008 Feb 15. J Pharm Biomed Anal. 2008. PMID: 18367363 Review.
-
Efficacy and Safety Profile of Diclofenac/Cyclodextrin and Progesterone/Cyclodextrin Formulations: A Review of the Literature Data.Drugs R D. 2016 Jun;16(2):129-40. doi: 10.1007/s40268-016-0123-2. Drugs R D. 2016. PMID: 26939533 Free PMC article. Review.
Cited by
-
Effect of Cyclodextrin Complex Formation on Solubility Changes of Each Drug Due to Intermolecular Interactions between Acidic NSAIDs and Basic H2 Blockers.Mol Pharm. 2023 Oct 2;20(10):5032-5042. doi: 10.1021/acs.molpharmaceut.3c00291. Epub 2023 Sep 9. Mol Pharm. 2023. PMID: 37688787 Free PMC article.
-
Supramolecular Complexation of Carbohydrates for the Bioavailability Enhancement of Poorly Soluble Drugs.Molecules. 2015 Oct 27;20(10):19620-46. doi: 10.3390/molecules201019620. Molecules. 2015. PMID: 26516835 Free PMC article. Review.
-
Perspectives in solubility measurement and interpretation.ADMET DMPK. 2019 Apr 5;7(2):88-105. doi: 10.5599/admet.686. eCollection 2019. ADMET DMPK. 2019. PMID: 35350542 Free PMC article. Review.
-
Effect of auxiliary substances on complexation efficiency and intrinsic dissolution rate of gemfibrozil-beta-CD complexes.AAPS PharmSciTech. 2010 Mar;11(1):27-35. doi: 10.1208/s12249-009-9350-y. Epub 2009 Dec 15. AAPS PharmSciTech. 2010. PMID: 20013079 Free PMC article.
-
Studies on the Preparation, Characterization, and Solubility of 2-HP-β-Cyclodextrin-Meclizine HCl Inclusion Complexes.J Young Pharm. 2012 Oct;4(4):220-7. doi: 10.4103/0975-1483.104365. J Young Pharm. 2012. PMID: 23493156 Free PMC article.
References
-
- Duchene D. New trends in cyclodextrins and derivatives. Paris: Editions de Santè; 1992. pp. 351–407.
-
- Frömming KH, Szejtli J. Cyclodextrins in Pharmacy, Topics in Inclusion Science. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1994.
-
- Thompson DO. Cyclodextrins-enabling excipients: their present and future use in pharmaceuticals. Crit Rev Ther Drug Carrier Syst. 1997;14:1–104. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources